Trial intelligence / Profile preview

Ozurdex in Cataract Surgery for Diabetic Macular Edema

NCT01546402Phase 4Completed

Sponsor
Post Graduate Institute of Medical Education and Research
Start
May 2011
Primary completion
Nov 2012
Modality
Implantable Devices, Implantable Hydrogels, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ozurdex in diabetic macular edema (DME), sponsored by Post Graduate Institute of Medical Education and Research. Started May 2011; status: completed.

02

Drugs

ozurdex
03

Conditions

diabetic macular edema (DME)

Beyond the preview

Go deeper on NCT01546402.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01546402.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call